Medicines and Healthcare Products Regulatory Agency
The question
To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what progress he has made on streamlining (a) regulation and (b) market access by supporting the Medicines and Healthcare products Regulatory Agency.
Answered by Kanishka Narayan
The Department for Science, Innovation and Technology offers support to all regulators through its Regulators’ Pioneer Fund, which is used for initiatives which improve the regulatory environment for innovation and investment. DSIT is contributing further to the development of the regulatory framework through its funding, alongside the Medicines and Healthcare products Regulatory Agency, Innovate UK and the Medical Research Council, of the Centres of Excellence for Regulatory Science and Innovation. Finally, the Regulatory Innovation Office has been working with DHSC, MHRA and other regulators to address the regulatory barriers to the development and adoption of AI and digital in healthcare.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →